Annual Review of Microbiology,
Год журнала:
2023,
Номер
77(1), С. 363 - 379
Опубликована: Июнь 12, 2023
The
gut
microbiome
is
a
dense
and
metabolically
active
consortium
of
microorganisms
viruses
located
in
the
lower
gastrointestinal
tract
human
body.
Bacteria
their
(phages)
are
most
abundant
members
microbiome.
Investigating
biology
interplay
between
two
important
if
we
to
understand
roles
health
disease.
In
this
review,
summarize
recent
advances
resolving
taxonomic
structure
ecological
functions
complex
community
phages
gut-the
phageome.
We
discuss
how
age,
diet,
geography
can
all
have
significant
impact
on
phageome
composition.
note
that
alterations
been
observed
several
diseases
such
as
inflammatory
bowel
disease,
irritable
syndrome,
colorectal
cancer,
evaluate
whether
these
changes
directly
or
indirectly
contribute
disease
etiology
pathogenesis.
also
highlight
lack
standardization
studying
has
contributed
variation
reported
results.
Nature Communications,
Год журнала:
2024,
Номер
15(1)
Опубликована: Фев. 29, 2024
Early-life
human
gut
microbiome
is
a
pivotal
driver
of
homeostasis
and
infant
health.
However,
the
viral
component
(known
as
"virome")
remains
mostly
unexplored.
Here,
we
establish
Early-Life
Gut
Virome
(ELGV),
catalog
160,478
non-redundant
DNA
RNA
sequences
from
8130
virus-like
particles
(VLPs)
enriched
or
bulk
metagenomes
in
first
three
years
life.
By
clustering,
82,141
species
are
identified,
68.3%
which
absent
existing
databases
built
mainly
adults,
64
8
based
on
VLPs-enriched
metagenomes,
respectively,
exhibit
potentials
biomarkers
to
distinguish
infants
adults.
With
largest
longitudinal
population
profiled
by
either
metagenomic
sequencing,
track
inherent
instability
temporal
development
early-life
virome,
identify
differential
viruses
associated
with
multiple
clinical
factors.
The
mother-infant
shared
virome
interactions
between
bacteriome
early
life
further
expanded.
Together,
ELGV
provides
most
comprehensive
complete
blueprint
facilitating
discovery
pediatric
disease-virome
associations
future.
Journal of Hepatology,
Год журнала:
2024,
Номер
81(2), С. 345 - 359
Опубликована: Март 28, 2024
The
rising
prevalence
of
liver
diseases
related
to
obesity
and
excessive
use
alcohol
is
fuelling
an
increasing
demand
for
accurate
biomarkers
aimed
at
community
screening,
diagnosis
steatohepatitis
significant
fibrosis,
monitoring,
prognostication
prediction
treatment
efficacy.
Breakthroughs
in
omics
methodologies
the
power
bioinformatics
have
created
excellent
opportunity
apply
technological
advances
clinical
needs,
instance
development
precision
personalised
medicine.
Via
technologies,
biological
processes
from
genes
circulating
protein,
as
well
microbiome
-
including
bacteria,
viruses
fungi,
can
be
investigated
on
axis.
However,
there
are
important
barriers
omics-based
biomarker
discovery
validation,
semi-quantitative
measurements
untargeted
platforms,
which
may
exhibit
high
analytical,
inter-
intra-individual
variance.
Standardising
methods
need
validate
them
across
diverse
populations
presents
a
challenge,
partly
due
disease
complexity
dynamic
nature
expression
different
stages.
Lack
validity
causes
lost
opportunities
when
studies
fail
provide
knowledge
needed
regulatory
approvals,
all
contributes
delayed
translation
these
discoveries
into
practice.
While
no
matured
implementation,
extent
data
generated
has
enabled
hypothesis-free
plethora
candidate
that
warrant
further
validation.
To
explore
many
hepatologists
detailed
commonalities
differences
between
various
layers,
both
advantages
approaches.
Humans
possess
abundant
amounts
of
microorganisms,
including
bacteria,
fungi,
viruses,
and
archaea,
in
their
gut.
Patients
with
nonalcoholic
fatty
liver
disease
(NAFLD)
exhibit
alterations
gut
microbiome
an
impaired
barrier
function.
Preclinical
studies
emphasize
the
significance
pathogenesis
NAFLD.
In
this
overview,
we
explore
how
adjusting
could
serve
as
innovative
therapeutic
strategy
for
We
provide
a
summary
current
information
on
untargeted
techniques
such
probiotics
fecal
microbiota
transplantation,
well
targeted
microbiome-focused
therapies
engineered
prebiotics,
postbiotics,
phages
treatment
Neural Regeneration Research,
Год журнала:
2023,
Номер
19(4), С. 833 - 845
Опубликована: Авг. 14, 2023
A
growing
body
of
evidence
suggests
that
the
gut
microbiota
contributes
to
development
neurodegenerative
diseases
via
microbiota-gut-brain
axis.
As
a
contributing
factor,
dysbiosis
always
occurs
in
pathological
changes
diseases,
such
as
Alzheimer's
disease,
Parkinson's
and
amyotrophic
lateral
sclerosis.
High-throughput
sequencing
technology
has
helped
reveal
bidirectional
communication
between
central
nervous
system
enteric
is
facilitated
by
microbiota's
diverse
microorganisms,
for
both
neuroimmune
neuroendocrine
systems.
Here,
we
summarize
bioinformatics
analysis
wet-biology
validation
metagenomics
with
an
emphasis
on
multi-omics
studies
virome.
The
pathogen-associated
signaling
biomarkers
identifying
brain
disorders
potential
therapeutic
targets
are
also
elucidated.
Finally,
discuss
role
diet,
prebiotics,
probiotics,
postbiotics
exercise
interventions
remodeling
microbiome
reducing
symptoms
diseases.
Although
changes
in
gut
microbiome
have
been
associated
with
the
development
of
T2D
and
its
complications,
role
virome
remains
largely
unknown.
Here,
we
characterized
alterations
complications
diabetic
nephropathy
(DN)
by
metagenomic
sequencing
fecal
viral-like
particles.
Compared
controls,
subjects,
especially
those
DN,
had
significantly
lower
viral
richness
diversity.
81
species
were
identified
to
be
altered
including
a
decrease
some
phages
(e.g.
Flavobacterium
phage
Cellulophaga
phaga).
DN
subjects
depleted
12
species,
Bacteroides
phage,
Anoxybacillus
virus
Brevibacillus
enriched
2
(Shigella
Xylella
phage).
Multiple
functions,
particularly
lysing
host
bacteria,
markedly
reduced
DN.
Strong
viral-bacterial
interactions
healthy
controls
disrupted
both
Moreover,
combined
use
bacterial
markers
achieved
powerful
diagnostic
performance
for
AUC
99.03%
98.19%,
respectively.
Our
results
suggest
that
complication
are
significant
diversity,
specific
loss
multiple
disruption
correlations.
The
potential
Nature Communications,
Год журнала:
2023,
Номер
14(1)
Опубликована: Сен. 12, 2023
Bacteriophages
(phages)
are
bacterial
viruses
that
have
been
shown
to
shape
microbial
communities.
Previous
studies
faecal
virome
transplantation
can
decrease
weight
gain
and
normalize
blood
glucose
tolerance
in
diet-induced
obese
mice.
Therefore,
we
performed
a
double-blind,
randomised,
placebo-controlled
pilot
study
which
24
individuals
with
metabolic
syndrome
were
randomised
filtrate
(FFT)
from
lean
healthy
donor
(n
=
12)
or
placebo
12).
The
primary
outcome,
change
metabolism,
secondary
outcomes,
safety
longitudinal
changes
within
the
intestinal
bacteriome
phageome,
assessed
baseline
up
28
days.
All
included
subjects
completed
analyses.
While
overall
metabolism
not
significantly
different
between
both
groups,
FFT
is
well-tolerated
without
any
serious
adverse
events.
phage
virion
composition
altered
two
days
after
as
compared
placebo,
coincides
more
virulent
phage-microbe
interactions.
In
conclusion,
provide
evidence
gut
phages
be
safely
administered
transiently
alter
microbiota
of
recipients.
Abstract
Obesity
is
a
metabolic
disorder
closely
associated
with
profound
alterations
in
gut
microbial
composition.
However,
the
dynamics
of
species
composition
and
functional
changes
microbiome
obesity
remain
to
be
comprehensively
investigated.
In
this
study,
we
conducted
meta-analysis
metagenomic
sequencing
data
from
both
obese
non-obese
individuals
across
multiple
cohorts,
totaling
1351
fecal
metagenomes.
Our
results
demonstrate
significant
decrease
richness
diversity
bacteriome
virome
patients.
We
identified
38
bacterial
including
Eubacterium
sp.
CAG:274,
Ruminococcus
gnavus
,
eligens
Akkermansia
muciniphila,
1
archaeal
species,
Methanobrevibacter
smithii
that
were
significantly
altered
obesity.
Additionally,
observed
abundance
five
viral
families:
Mesyanzhinovviridae
Chaseviridae
Salasmaviridae
Drexlerviridae
Casjensviridae
.
Functional
analysis
indicated
distinct
signatures
as
primary
driver
for
function
enrichment
obesity,
muciniphila
bicirculans
siraeum
drivers
healthy
control
group.
our
suggest
antibiotic
resistance
genes
virulence
factors
may
influence
development
Finally,
demonstrated
vOTUs
achieved
diagnostic
accuracy
an
optimal
area
under
curve
0.766
distinguishing
controls.
findings
offer
comprehensive
generalizable
insights
into
features
potential
guide
microbiome-based
diagnostics.
npj Biofilms and Microbiomes,
Год журнала:
2024,
Номер
10(1)
Опубликована: Март 29, 2024
Abstract
Crosstalk
of
microbes
with
human
gut
epithelia
and
immune
cells
is
crucial
for
health.
However,
there
no
existing
system
a
long-term
co-culture
innate
epithelium
oxygen-intolerant
commensal
microbes,
hindering
the
understanding
microbe-immune
interactions
in
controlled
manner.
Here,
we
established
epithelium-microbe-immune
(GuMI)
microphysiological
to
maintain
continuous
Faecalibacterium
prausnitzii/Faecalibacterium
duncaniae
colonic
epithelium,
antigen-presenting
(APCs,
herein
dendritic
macrophages),
CD4
+
naive
T
circulating
underneath
epithelium.
In
GuMI-APC
condition,
multiplex
cytokine
assays
suggested
that
APCs
contribute
elevated
level
cytokines
chemokines
secreted
into
both
apical
basolateral
compartments
compared
GuMI
condition
lacks
APC.
F.
prausnitzii
(GuMI-APC-FP),
increased
transcription
pro-inflammatory
genes
such
as
toll-like
receptor
1
(
TLR1
)
interferon
alpha
IFNA1
without
significant
effect
on
secretion,
bacteria
(GuMI-APC-NB).
contrast,
presence
(GuMI-APCT-FP),
,
IDO1
levels
decreased
simultaneous
increase
-induced
secretion
(e.g.,
IL8)
GuMI-APC-FP
cells.
These
results
highlight
contribution
individual
regulating
response
triggered
by
.
The
integration
defined
populations
demonstrated
usefulness
physiomimetic
platform
study
microbe-epithelial-immune
healthy
disease
conditions.
Hepatology,
Год журнала:
2024,
Номер
80(6), С. 1424 - 1440
Опубликована: Май 31, 2024
New
guidelines
for
the
definitions
of
steatotic
liver
disease
have
named
entity
metabolic
dysfunction
and
alcohol-associated
(MetALD)
as
an
overlap
condition
dysfunction–associated
(MASLD)
disease.
There
is
a
broad
range
therapeutics
in
all
stages
development
MASLD,
but
these
therapeutics,
general,
not
been
studied
patients
with
significant
ongoing
alcohol
use.
In
this
review,
we
discuss
current
understanding
endogenous
exogenous
risks
MASLD
MetALD.
Rational
strategies
therapeutic
intervention
MetALD
include
biopsychosocial
interventions,
use
cessation
strategies,
including
medications
disorder,
judicious
Therapeutics
promise
incretin-based
therapies,
FGF21
agonists,
thyroid
hormone
receptor
beta
sodium-glucose
co-transporter
2
inhibitors,
agents
to
modify
de
novo
lipogenesis.
Currently,
glucagon-like
peptide
1
agonists
peroxisome
proliferator–activated
γ
largest
body
literature
supporting
their
there
paucity
trials
From
existing
studies,
it
clear
if
unique
or
combinatorial
approach
are
needed
Further
elucidation
safety
benefits
MASLD-related
therapies
paramount
importance
advancing
carefully
designed
inclusive
clinical
trials.